"Click Chemistry" Concept Inspires BiOLinkMatrix by HALLURA™: the Next Generation of HA Dermal Fillers
YOKNEAM, Israel, Nov. 10, 2022 /PRNewswire/ -- Hallura Ltd., an Israeli aesthetic medical company, announced today that its proprietary technology named the BiOLinkMatrix platform was inspired by the 2022 Nobel Prize for Click Chemistry. Harnessing this concept, Hallura's products revolutionize the way Hyaluronic Acid (HA) is cross-linked in dermal fillers for great elasticity and tolerance while being biodegradable and highly safe.
- Harnessing this concept, Hallura's products revolutionize the way Hyaluronic Acid (HA) is cross-linked in dermal fillers for great elasticity and tolerancewhile being biodegradable and highly safe.
- Hallura harnessed this advanced concept in its proprietary BiOLinkMatrix platform to revolutionize the way HA is crosslinked in Dermal Fillers.
- Typical HA dermal fillers are cross-linked viathe chemical BDDE, or other epoxides, activated under harsh conditions with very little control over concurrent damage to the HA polymer.
- Hallura's HA dermal fillers answer the growing demand for better, safer fillers with natural and soft aesthetic results.